CLINICAL_TRIALS
ClinicalTrials.gov record update
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07023861
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:40.780465+00:00
- Published At
- 2025-06-17T00:00:00+00:00
- Record Updated At
- 2025-06-17
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Breast Cancer", "Gastric Cancer (GC)", "Urothelial Carcinoma (UC)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-17"- protocolSection.identificationModule.nctId
"NCT07023861"- protocolSection.identificationModule.officialTitle
"The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies"- protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.